Mentions
Extended reach
Total likes
Video views
AI synopsis
The collective discussions show strong interest and support for the article, with posts celebrating research milestones, connecting to previous studies, and mentioning application of findings in clinical and academic contexts. For example, references to collaborations with notable researchers and involvement in follow-up studies like the Hyperglycemia Follow-Up Study highlight ongoing engagement and perceived significance, while the tone remains respectful and optimistic about future research potential.
Most posts express support or positive acknowledgment of the research, highlighting its importance and contributions, indicating general agreement with the findings.
The discussions reflect high engagement with the topic through references to specialized studies, ongoing research, and academic collaborations, showing significant interest.
The posts vary from sharing brief mentions to detailed recollections and connections to future research, demonstrating moderate participation levels.
The discussions point to the study's influence on ongoing research, grants, and clinical practices, suggesting they see it as impactful but not revolutionary.
I’m still remember when as PhD student in Chile I read the HAPO study many times - I couldn't have imagined that 15 years later would be collaborating with Boyd Metzger and Bill Lowe from @NUFeinbergMed - EVs & Hyperglycemia and Adverse Pregnancy Outcomes @UQMedicine #uqccr https://t.co/hjL22j5fQV
This year marks 60 years of @KPSCalResearch innovation and research, such as our contribution to the Hyperglycemia and Adverse Pregnancy Outcomes study in 2000. Our researchers started its third phase in 2023 to assess cardiovascular health in offspring.
Hyperglycemia and Adverse Pregnancy Outcomes [Citation Classic] https://t.co/oVe9IjEOxV
Congratulations to our @ManneResearch Internal Grant Awardees! Dr. Wendy Brickman has received a Proposal Revision Award for "Revisions for #Hyperglycemia and Adverse Pregnancy Outcomes Study—Cardiovascular Health of HAPO Offspring (HAPO CVH)" https://t.co/CwdaE70zJD https://t.co/P2uPjmCQSY
El uso de hemoglobina glicada como prueba de tamización para diabetes gestacional entre las semanas 24-28 no tiene la misma sensibilidad que las pruebas de tolerancia oral descritas. [https://t.co/nVrdwOxYpX]
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoGj92 https://t.co/7QrUfsGm0c
Maternal hyperglycemia below diabetic levels is linked to higher risks of adverse pregnancy outcomes such as high birth weight, cesarean delivery, and neonatal hypoglycemia, with increased odds ratios corresponding to…
This episode explores dietary strategies for pregnant women with gestational diabetes, comparing higher-complex-carbohydrate and lower-carb diets, which show similar outcomes in newborn adiposity and maternal glucose…
Just published in Pediatric Obesity: "Leptin and adiposity measures from birth to later childhood: Findings from the Hyperglycemia and Adverse Pregnancy Outcomes Follow‐Up Study". https://t.co/7ffWTig8oI
Leptin and adiposity measures from birth to later childhood: Findings from the Hyperglycemia and Adverse Pregnancy Outcomes Follow-Up Study https://t.co/Xjgw6Q0lWd https://t.co/rIaKwvYvfl
Just published in Pediatric Obesity: "Leptin and adiposity measures from birth to later childhood: Findings from the Hyperglycemia and Adverse Pregnancy Outcomes Follow‐Up Study". https://t.co/7ffWTig8oI
RT @kphistory: This year marks 60 years of @KPSCalResearch innovation and research, such as our contribution to the Hyperglycemia and Adver…
RT @kphistory: This year marks 60 years of @KPSCalResearch innovation and research, such as our contribution to the Hyperglycemia and Adver…
This year marks 60 years of @KPSCalResearch innovation and research, such as our contribution to the Hyperglycemia and Adverse Pregnancy Outcomes study in 2000. Our researchers started its third phase in 2023 to assess cardiovascular health in offspring.
@squeeshymeeshy @saaiyer The study Sangeetha. https://t.co/7Qc3VRKEPF
I’m still remember when as PhD student in Chile I read the HAPO study many times - I couldn't have imagined that 15 years later would be collaborating with Boyd Metzger and Bill Lowe from @NUFeinbergMed - EVs & Hyperglycemia and Adverse Pregnancy Outcomes @UQMedicine #uqccr https://t.co/hjL22j5fQV
Congratulations to our @ManneResearch Internal Grant Awardees! Dr. Wendy Brickman has received a Proposal Revision Award for "Revisions for #Hyperglycemia and Adverse Pregnancy Outcomes Study—Cardiovascular Health of HAPO Offspring (HAPO CVH)" https://t.co/CwdaE70zJD https://t.co/P2uPjmCQSY
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes https://t.co/dVWufdDSkz #Endocrinology
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoXUxC https://t.co/7QrUfsXXoM
@MHLahaye @WitchKnits Les études sur le dépistage du diabète gestationnel ont été faites sur 23000 patientes en population générale. Les seuils retenus sont ceux définis sur un risque de +75% de complications (pour la grossesse en cours) pour un taux de 12-15% de dépistage +. https://t.co/zAUBp1f0tW
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoGj92 https://t.co/7QrUfsGm0c
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoGj92 https://t.co/7QrUfsGm0c
El uso de hemoglobina glicada como prueba de tamización para diabetes gestacional entre las semanas 24-28 no tiene la misma sensibilidad que las pruebas de tolerancia oral descritas. [https://t.co/nVrdwOxYpX]
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoXUxC https://t.co/7QrUfsXXoM
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoGj92 https://t.co/7QrUfsGm0c
RT @2minmed: The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoGj92 https://t.co…
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoGj92 https://t.co/7QrUfsGm0c
Hyperglycemia and Adverse Pregnancy Outcomes. https://t.co/Lz5mxjoOn8 https://t.co/KTyL2pB2RJ
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoGj92 https://t.co/7QrUfsGm0c
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoGj92 https://t.co/7QrUfsGm0c
RT @Clin_Chem_AACC: Hyperglycemia and Adverse Pregnancy Outcomes [Citation Classic] https://t.co/oVe9IjEOxV
RT @Clin_Chem_AACC: Hyperglycemia and Adverse Pregnancy Outcomes [Citation Classic] https://t.co/oVe9IjEOxV
RT @Clin_Chem_AACC: Hyperglycemia and Adverse Pregnancy Outcomes [Citation Classic] https://t.co/oVe9IjEOxV
Hyperglycemia and Adverse Pregnancy Outcomes [Citation Classic] https://t.co/oVe9IjEOxV
The HAPO trial: hyperglycemia and adverse pregnancy outcomes [Classics Series] Read more: https://t.co/qtz7GoGj92 https://t.co/7QrUfsGm0c
doi: 10.1056/NEJMoa0707943. pmid:18463375. 8. International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson ...
N Engl J Med. 2008 May 8;358(19):1991-2002. doi: 10.1056/NEJMoa0707943. Dra. Mariana Rialto US em Ginecologia e Obstetrícia | Medicina Fetal
doi: 10.1056/NEJMoa0707943. PMID: 18463375. Dostupné na: https://www.nejm.org/doi/full/10.1056/NEJMoa0707943. Pozn.: Hodnoty ve studii jsou ...
... 10.1056/NEJMoa0707943. PMID: 18463375. Dostupné na: https://www.nejm.org/doi/full/10.1056/NEJMoa0707943 Pozn.: Hodnoty ve studii jsou ...
... 10.1056/NEJMoa0707943. In short, there is no clear cutoff. The risk increases progressively with higher glucose. Community Info Section. r ...
doi: 10.1056/NEJMoa0707943. Dra. Mariana Rialto US em Ginecologia e Obstetrícia | Medicina Fetal CRM-PR 32.521 RQE 24674 | 24812 #gestação ...
doi: 10.1056/NEJMoa0707943. Dra. Mariana Rialto US em Ginecologia e Obstetrícia | Medicina Fetal CRM-PR 32.521 RQE 24674 | 24812 #gestação ...
https://www.nejm.org/doi/full/10.1056/nejmoa0707943. Some studies show that pregnant women without GD do experience blood sugars higher than ...
org/doi/full/10.1056/NEJMoa0707943#t=abstract 註五： http://www.books.com. tw/products/0010770074 註六：https://www.sciencedirect. com ...
doi: 10.1056/NEJMoa0707943. International Associated of Diabetes and Pregnancy Study Groups Consensus Panel. International Association ...
... 10.1056/NEJMoa0707943#t=article, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827530/, http://www.nejm.org/doi/full/10.1056/NEJMoa042973#t ...
2008;doi:10.1056/NEJMoa0707943. Robert E. Ratner, MD, FACP, FACE. Chief Scientific & Medical Officer, American Diabetes Association. Associate ...
CS
KH
CC
SI
JU
MM
LN
AP
CD
KR
DA
I
NJ
MM
MD
B
G
PZ